Literature DB >> 32063610

Postpartum depression and breastfeeding in overweight/obese and non-obese mothers.

Feyza Ertop1, Nuray Egelioglu Cetisli2.   

Abstract

OBJECTIVE: To analyse depression and breastfeeding behaviour of overweight/obese and non-obese primipara mothers during their pregnancy and postpartum period.
METHODS: The comparative cross-sectional study was conducted at Afyonkarahisar State Hospital, Afyonkarahisar, Turkey, from September 2016 to February 2017, and comprised three follow-ups of overweight/obese and nonobese pregnant women. Data was collected using a personal identification form, and standard postpartum depression and breast feeding definition scales. SPSS 22 was used for data analysis.
RESULTS: Of the 229 subjects, 110(48%) were overweight/obese and 119(52%) were non-obese. The difference between the two groups was statistically significant regarding the mode of delivery and exclusive breastfeeding (p<0.05). Depression scores of overweight/obese mothers were higher in prenatal period, on the postpartum second day and in the postpartum 4th-6th week (p<0.05). The breastfeeding scores of overweight / obese mothers were low on the postpartum second day and in the postpartum 4th-6th week (p<0.05). There was a negative correlation between depression and breastfeeding scores of all mothers in both prenatal and postpartum periods (p<0.05 each).
CONCLUSIONS: Health professionals should support obese women because they carry a risk of prenatal and postpartum depression as well as unsuccessful breastfeeding.

Entities:  

Keywords:  Breastfeeding, Depression, Obese pregnant, Overweight pregnant.zzm321990zzm321990

Mesh:

Year:  2020        PMID: 32063610     DOI: 10.5455/JPMA.302642854

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  1 in total

1.  Association of high Body Mass Index and postdates pregnancy.

Authors:  Qudsia Qazi; Nazia Liaqat; Shehzadi Saima Hussain; Wajeeha Syed
Journal:  Pak J Med Sci       Date:  2022 May-Jun       Impact factor: 2.340

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.